University of Cincinnati

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, University of Cincinnati sits in the top decile of US sponsors by registered trial count (#133 of 15,742 sponsors by registered trial count).

245 total trials 34 currently recruiting 172 completed top decile by trial count

University of Cincinnati: 245 sponsored US clinical trials, 34 recruiting.

University of Cincinnati sponsors 245 registered US clinical trials on ClinicalTrials.gov, 34 of them currently recruiting, and 172 completed. 65 of these trials are in Phase 3-4 (later-stage) and 56 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Stroke, with 9 trials.

Top-decile sponsor footprint

University of Cincinnati ranks in the top decile of sponsors by registered trial count (#133 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 67/100

172 of 189 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

245 total, page 2 of 5

ACTIVE NOT RECRUITING NA

3-Tesla MRI in Finding Tumors in Patients With Known or Suspected Prostate Cancer

NCT01653093

ACTIVE NOT RECRUITING NA

MRI in Diagnosing Solid Tumors of the Eye and Orbit

NCT01653080

ACTIVE NOT RECRUITING

A Comparison of Hemorrhagic and Ischemic Strokes Among Blacks and Whites

NCT00642213

NOT YET RECRUITING NA

Safety And Effectiveness Of NaviFUS System With Bevacizumab In Recurrent Glioblastoma

NCT07274787

NOT YET RECRUITING NA

Promoting Adherence to Chemotherapy Handling Guidelines Among Oncology Nurses

NCT06919653

NOT YET RECRUITING NA

Measuring the Feasibility and Effect of a Virtual Reality Cognitive Training Intervention for Brain Cancer Survivors.

NCT07313709

TERMINATED NA

Gender-affirming Voice Training With Visual Feedback

NCT07017595

COMPLETED NA

Bipolar Disorder Measures in Clinical Care

NCT05300919

COMPLETED NA

The Effect of Immediate Versus Delayed Debriefing on Basic Life Support Competence In Undergraduate Nursing Students.

NCT06624449

COMPLETED NA

A Health Game Intervention for Cancer and Post-ICU Patients Suffering From Acute Cognitive Impairment

NCT07596940

COMPLETED NA

CanRestoreFunction Cancer-related Fatigue ( CRF )

NCT05868187

COMPLETED

Oximeters and Skin Pigment: Impact of Skin Pigmentation on Accuracy of Pulse Oximetry

NCT05690269

COMPLETED NA

Developing an EEG Probe for Studying and Modulating Cognitive Control

NCT05612659

COMPLETED NA

Lingual Endurance Exercise in Treating Post-Stroke Dysphagia

NCT05523973

COMPLETED NA

Healthy Eating for My Infant (HEMI)

NCT04977947

COMPLETED NA

PREEMIE PROGRESS: A Family Management Program for Parents of Preterm Infants

NCT04638127

COMPLETED Phase 4

Effects of Diazepam on RNS Detections

NCT05273398

COMPLETED NA

Motor Control Physical Therapist Support Stroke

NCT04856527

COMPLETED

HRV as a Marker of Treatment Response in PAH Arterial Hypertension

NCT04451850

COMPLETED NA

Evaluating the Impact of Vocal Health Education on Mask-wearing Workers During COVID-19

NCT04858542

COMPLETED NA

Stress-reduction Wellness Program for Midlife Black Women (B-SWELL)

NCT04404478

COMPLETED NA

The Role of the Circadian System in Binge Eating Disorder

NCT04724668

COMPLETED

A Pharmacokinetic Analysis of Levetiracetam Prophylaxis in Critically Ill Patients With Severe Traumatic Brain Injury

NCT04836481

COMPLETED NA

EHR-Embedded Decision Support to Prevent Stroke in Patients With AF

NCT04099485

COMPLETED Phase 4

Studies of COVID-19 Patients Treated With Oral Bismuth Subsalicylate (Pepto-Bismol)

NCT04811339

COMPLETED NA

Optimizing Training in Severe Post-Stroke Walking Impairment

NCT04721860

COMPLETED NA

Quantifying the Role of Sensory Systems Processing in Post-Stroke Walking Recovery

NCT04553198

COMPLETED Phase 2

Sirolimus Treatment in Hospitalized Patients With COVID-19 Pneumonia

NCT04341675

COMPLETED Phase 2

Blood Pressure After Endovascular Stroke Therapy-II

NCT04116112

COMPLETED Phase 4

Efficacy of Hematoma Block on Postoperative Pain After Femoral Intramedullary Rodding: A Randomized Trial

NCT04860856

COMPLETED Phase 1

CCR5-modified CD4+ T Cells for HIV Infection

NCT03666871

COMPLETED NA

Effect of Fasting on Insulin-induced Hypoglycemia Counterregulation in Healthy Humans

NCT04392843

COMPLETED NA

Supermarket and Web-Based Intervention Targeting Nutrition (SuperWIN) for Cardiovascular Risk Reduction

NCT03895580

COMPLETED Phase 4

Liposomal Bupivacaine Versus Interscalene Nerve Block

NCT03929146

COMPLETED NA

Moderate-Intensity Exercise Versus High-Intensity Interval Training to Recover Walking Post-Stroke

NCT03760016

COMPLETED Phase 3

Inhaled Nitric Oxide in Brain Injury

NCT03260569

COMPLETED NA

Healthy Start to Feeding Intervention

NCT03597061

COMPLETED Phase 1

Spinal Cord Stimulation for the Treatment of Major Depressive Disorder

NCT03433339

COMPLETED Phase 4

Anesthesia for Pain After Ankle Fracture Surgery

NCT02950558

COMPLETED NA

Caregiver Self-Management Needs Through Skill-Building

NCT03635151

COMPLETED Phase 2

Resveratrol and Sirolimus in Lymphangioleiomyomatosis Trial

NCT03253913

COMPLETED Phase 2

Intercostal Liposomal Bupivacaine for the Management of Blunt Chest Wall Trauma

NCT02749968

COMPLETED NA

EMPOWER: Randomized Trial of Online Chronic Pain Management Program to Reduce Reliance on Opioid Analgesic Medications

NCT03308188

COMPLETED NA

Hypofractionated Radiotherapy for Recurrent DIPG

NCT03841435

COMPLETED NA

AWAITS: A Web-based E-health Application for Active Illicit Opioid Users

NCT03402672

COMPLETED NA

RETAIN: Retaining Opioid Users Entering Medication Assisted Treatment and Encouraging HCV/HIV Testing

NCT03411265

COMPLETED NA

Feasibility Study of Modified Atkins Ketogenic Diet in the Treatment of Newly Diagnosed Malignant Glioma

NCT03278249

COMPLETED NA

A Comparison of CPT Versus ART Versus WL

NCT03384706

COMPLETED Early Phase 1

Impact of Topical Tranexamic Acid on Pre- and Post-operative Hemoglobin/Hematocrit

NCT05357079

COMPLETED Phase 2

Budesonide for Liver Transplant Immune Suppression

NCT03304626

← Previous Page 2 of 5 Next →

Phase Distribution

PhaseTrial count
Phase 1 23
Phase 2 33
Phase 3 19
Phase 4 46

What is open in the University of Cincinnati pipeline

34 recruiting of 245 indexed (14% open); 172 completed (70%).

Phase mix: 65 late (III/IV) vs 56 early (I/II) (balanced across stages).

Top condition: Stroke (9 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Cincinnati: open-pipeline peers nationwide

Peers matched on 245 registered trials and 14% open enrollment, not the therapeutic-area sidebar.

University of Cincinnati sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0100200300400500 0%5%10%15%20%25% Total trials Recruiting share University of CincinnatiShireState University of New York at BuffaloMasonic Cancer Center, University of MinnesotaUniversity of Massachusetts, WorcesterMilton S. Hershey Medical CenterJohns Hopkins Bloomberg School of Public HealthBeiGeneSeattle Institute for Biomedical and Clinical Research
University of Cincinnati sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Cincinnati sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 245 trials (± recruiting share)

Sponsors near 14% open enrollment (± trial volume)

What to do with this University of Cincinnati page

245 registered trials is a research-attention snapshot, not an endorsement of University of Cincinnati or any single study.

  • 34 of University of Cincinnati's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Stroke is the condition University of Cincinnati studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Stroke trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Cincinnati pipeline card: 245 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.